To view the fulltext, please log in
To view the pdf, please log in
Menstrual disorders are very common in adolescence, and can be the cause of a significant amount of stress to both the patients and their parents. Variations of the menstrual cycle in this age are very broad and are mainly caused by the immaturity of the hypothalamic-pituitary-ovarian (HPO) axis. Amenorrhea (either primary or secondary), abnormal uterine bleeding and dysmenorrhea are conditions that require careful evaluation through a stepwise and logical manner. The term primary amenorrhea refers to the condition when menarche fails to occur, while secondary amenorrhea refers to the cessation of menses once they have begun. The occurrence of irregular, prolonged or heavy abnormal uterine bleeding is one of the most urgent gynecological problems in adolescence and the diagnosis of dysfunctional uterine bleeding should be used only when all other organic and structural causes of abnormal vaginal bleeding have been ruled out. Dysmenorrhea refers to painful menstruation and is the most common reason for which a young girl may refer to a gynecologist. It is characterized as primary in the absence of an underlying organic disease, and as secondary when there is evidence of pelvic pathology. Appropriate and early management of the patient is necessary in order to minimize the possibility of future complications regarding woman’s reproductive ability.
Copyright / Drug Dosage
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
- American Academy of Pediatrics Committee on Adolescence: American College of Obstetricians and Gynecologists Committee on Adolescent Health Care: Diaz A, Laufer MR, Breech LL: Menstruation in girls and adolescents: using the menstrual cycle as a vital sign. Pediatrics 2006;118:2245-2250
- Ibáñez L, Potau N, Zampolli M, et al: Hyperinsulinemia and decreased insulin-like growth factor-binding protein-1 are common features in prepubertal and pubertal girls with a history of premature pubarche. J Clin Endocrinol Metab 1997;82:2283-2288
- Deligeoroglou E, Tsimaris P, Deliveliotou A, et al: Menstrual disorders during adolescence. Pediatr Endocrinol Rev 2006;3:(suppl 1)150-159
- World Health Organization Task Force on Adolescent Reproductive Health: World Health Organization multicenter study on menstrual and ovulatory patterns in adolescent girls. II. Longitudinal study of menstrual patterns in the early postmenarcheal period, duration of bleeding episodes and menstrual cycles. J Adolesc Health Care 1986;7:236-244
- The Practice Committee of the American Society for Reproductive Medicine: Current evaluation of amenorrhea. Fertil Steril 2008;90:(suppl 3)S219-S225
- Patel SS, Bamigboye V: Hyperprolactinaemia. J Obstet Gynaecol 2007;27:455-459
- Nelson LM: Primary ovarian insufficiency. N Engl J Med 2009;360:606-614
- Fraser IS, Sungurtekin U: Defining menstrual disturbances. (eds) in Maclean A, O’Brien PMS (eds): Study Group on Menstrual Disorders London, Royal College of Obstetricians and Gynecologist, 2000;141-152
- Minjarez DA, Bradshaw KD: Abnormal uterine bleeding in adolescents. Obstet Gynecol Clin North Am 2000;27:63-78
- Claessens EA, Cowell CA: Dysfunctional uterine bleeding in the adolescent. Pediatr Clin North Am 1981;28:369-378
- Kouides PA: Obstetric and gynaecological aspects of von Willebrand disease. Best Pract Res Clin Haematol 2000;14:381-399
- Kadir RA, Aledort LM: Obstetrical and gynaecological bleeding: a common presenting symptom. Clin Lab Haematol 2000;22:(suppl 1)12-16
- Mammen EF: Haemostatic dysfunction related to liver diseases and liver transplantation. (eds) in Beutler E, Lichtman MA, Coller BS, et al (eds): Williams Hematology 6New York, McGraw-Hill Professional, 2001;1673-1676
- Deligeoroglou E: Dysfunctional uterine bleeding. Ann NY Acad Sci 1997;816:158-164
- Kriplani A, Kulshrestha V, Agarwal N, Diwakar S: Role of tranexamic acid in management of dysfunctional uterine bleeding in comparison with medroxyprogesterone acetate. J Obstet Gynaecol 2006;26:673-678
- Andersch B, Milsom I: An epidemiologic study of young women with dysmenorrhea. Am J Obstet Gynecol 1982;144:655-660
- Creatsas G, Deligeoroglou E, Zachari A, et al: Prostaglandins: PGF2 alpha, PGE2, 6-keto-PGF1 alpha and TXB2 serum levels in dysmenorrheic adolescents before, during and after treatment with oral contraceptives. Eur J Obstet Gynecol Reprod Biol 1990;36:292-298
- Deligeoroglou E: Dysmenorrhea. Ann NY Acad Sci 2000;900:237-244